Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-10-001547
Filing Date
2010-02-26
Accepted
2010-02-26 16:54:41
Documents
8
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2196774z10-k.htm 10-K 1432321
2 EXHIBIT 10.2 a2196774zex-10_2.htm EX-10.2 99286
3 EXHIBIT 21.1 a2196774zex-21_1.htm EX-21.1 5778
4 EXHIBIT 23.1 a2196774zex-23_1.htm EX-23.1 3428
5 EXHIBIT 31.1 a2196774zex-31_1.htm EX-31.1 7733
6 EXHIBIT 31.2 a2196774zex-31_2.htm EX-31.2 7788
7 EXHIBIT 32.1 a2196774zex-32_1.htm EX-32.1 4210
8 EXHIBIT 32.2 a2196774zex-32_2.htm EX-32.2 4303
  Complete submission text file 0001047469-10-001547.txt   1566341
Mailing Address 100 HAYDEN AVENUE LEXINGTON MA 02140
Business Address 100 HAYDEN AVENUE LEXINGTON MA 02140 6174972070
AMAG PHARMACEUTICALS INC. (Filer) CIK: 0000792977 (see all company filings)

EIN.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-10865 | Film No.: 10640228
SIC: 2835 In Vitro & In Vivo Diagnostic Substances